0102030405
CAS 204656-20-2 Liraglutide China kyakkyawan masana'anta kai tsaye tallace-tallace Babban Tsafta Tsaro jigilar kaya mai inganci daidai farashin manyan masu siye gamsuwa da Isar da sauri
Bayanin samfur
Liraglutide shine GLP-1 (1-37) wanda aka gyara a Ly: ƙungiyar -amino an haɗa shi da wani nau'in (N-hexadecanoyl) glutam--yl wanda ba tare da haɗin gwiwa ba amma yana ɗaure ɗan adam albumin. (Har ila yau, an maye gurbin Lys tare da Arg.) Waɗannan canje-canje suna ba da damar ƙara yawan jini t1?2 na 10 zuwa 15 hours bayan gudanarwar sc (0.6-1.8 MG), yana ba da damar yin amfani da sau ɗaya kowace rana. Liraglutide (Victoza, Novo Nordisk) yana jiran amincewar FDA, EMEA, da Koˉ roˉ -shoˉ (Japan).
samfurin bidiyo
Aikace-aikacen samfur
Liraglutide wani sabon nau'in maganin hypoglycemic ne wanda ke kunna furotin da ke kunna AMP don haka yana haɓaka hankalin insulin. Ba wai kawai yana da tasiri mai mahimmanci na hypoglycemic ba, har ma yana da ayyuka na asarar nauyi, rage karfin jini, da haɓaka bayanan lipid na jini.
Liraglutide, ɗan adam glucagon-kamar peptide-1 (GLP-1) agonist mai karɓa, yana jinkirin zubar ciki, yana ƙara koshi, kuma yana rage cin abinci mara lafiya, yayin da rage sha'awar ci da ƙyale jiki don ƙara yawan kashe kuzari yana taka rawa wajen nauyi. hasara; yana hana hanta samar da glucose da yawa kuma yana inganta pancreas don samar da ƙarin insulin don rage sukarin jini; Bugu da kari, liraglutide kuma yana da fa'idodin zuciya da jijiyoyin jini da kuma kariyar koda.
ƙayyadaddun samfur
| Sunan gama gari | Liraglutide |
| Lambar CAS | 204656-20-2 |
| Tsarin kwayoyin halitta | Saukewa: C172H265N43O51 |
| Nauyin Kwayoyin Halitta | 3751.20000 |
PSA | 1513.76000 |
LogP | 6.12960 |
EINECS | 810-818-7 |
Kunshin
Jirgin ruwa
FAQ
bayanin kamfanin
factory & Warehouse
Amfaninmu
